The report of Global Orphan Diseases Market by Market Research Future comprises of
extensive primary research along with the detail analysis of qualitative as well as
quantitative aspects by various industry experts and key opinion leaders to gain a deeper
insight of the market and industry performance. Global Orphan Diseases Market also known
as rare disease is growing rapidly. It affects a very small percentage of the global
population. Most of the orphan diseases are genetic and is remains throughout the life of
the patient. There are no exact number of diseases available but approximately there are
about 7000 different rare diseases and disorders throughout the globe. Global Orphan
Diseases Market is expected to grow at the average CAGR of 24.9% constantly throughout
this period 2015-2022. It is also expected that this market which was US$ 121.6 billion in
2015 will grow to US$ 576.9 billion by 2022. . However due to lack of awareness, correct
diagnosis, correct treatments and availability of healthcare facilities are inhibiting the
growth of the Global Orphan Diseases Market.
Global Orphan Diseases Market has been segmented on the basis of types of diseases which
includes autoimmune disorders, genetic disorders, blood disorders, cancer, growth disorder,
cardiovascular diseases, neurological disorders, respiratory disorders, digestive disorders,
eye disorders and others. On the basis of treatment type it segmented into gene therapy,
cell therapy, drug therapy and others. On the basis of end user the market is segmented
into hospital and clinics, research laboratory and others.
Key Players for Global Orphan diseases Market:
Bristol-Myers Squibb Company (US), Novartis AG (Switzerland), CELGENE CORPORATION
(US), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Alexion (US), Sanofi
(French), Vertex Pharmaceuticals Incorporated (US), GlaxoSmithKline plc. (UK), Merck &
Co., Inc (US), AbbVie Inc. (US)
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2547 .
Considering the global scenario of this market, North American region is believed to be the
largest market of the Global Orphan Diseases Market. Moreover the European market is also
growing and is the second largest market for global orphan diseases. On the other hand,
Asia-Pacific’s orphan disease market is expected to grow at a significant rate during the
forecasted period. Rest of the World is likely to have a limited but steady growth with
respect to this market.
The report gives a clear picture of current market scenario which includes past and
estimated future market size with respect to value and volume, technological advancement,
macro economical and governing factors in the market. The report provides detail
information about and strategies used by top key players in the industry. The report also
gives a broad study of different markets segments and regions.